摘要
随着放疗技术和其他肺癌治疗技术的发展,放疗在不同分期非小细胞肺癌(non-small cell lung cancer,NSCLC)治疗中的应用模式发生了一定程度的改变。对于不能手术的早期NSCLC首选立体定向放射治疗(stereotactic body radiotherapy,SBRT),但应注意SBRT的毒性管理;同步放化疗是局部晚期NSCLC安全有效的治疗方法,局部晚期NSCLC行术后辅助放疗可能使患者获益;晚期NSCLC寡转移或寡复发均可行局部治疗;放疗联合免疫治疗NSCLC正在悄然改变着肺癌的治疗模式。
With the development of radiotherapy technology and other lung cancer treatment technologies,the application modes of radiotherapy in the treatment of non-small cell lung cancer(NSCLC)at different stages changed to some extent.Stereotactic body radiotherapy(SBRT)is preferred for inoperable early NSCLC,but attention should be paid to the management of SBRT toxicity.Concurrent chemoradiotherapy is a safe and effective treatment for locally advanced NSCLC,and postoperative adjuvant radiotherapy for locally advanced NSCLC may benefit patients.Local treatment is feasible for oligometastasis or oligo-recurrence of advanced NSCLC.Radiation combined with immunotherapy for NSCLC is quietly changing the treatment of lung cancer.
作者
白玉君
魏玉春
袁双虎
Bai Yujun;Wei Yuchun;Yuan Shuanghu(Department of Radiology,Shandong Cancer Hospital and Institute;Shandong First Medical University and Shandong Academy of Medical Sciences,Jinan 250117,China)
出处
《肿瘤综合治疗电子杂志》
2020年第2期90-95,共6页
Journal of Multidisciplinary Cancer Management(Electronic Version)
关键词
非小细胞肺癌
放射治疗
进展
Non-small cell lung cancer
Radiotherapy
Advance
